Company
Mahzi Therapeutics
Mahzi is focused on treating under-served rare genetic neurodevelopmental disorders.
- Status
- Operatingas of 2026-09-17
Claim, correct or request removal
Record updated 28 September 2026
About
Mahzi, which is based on the Greek word for “Together”, aims to unite patient and family groups, academic researchers, other industry members, and our internal team of experts to develop therapies for patients with under-diagnosed and under-served rare genetic neurodevelopmental disorders.
Funding snapshot
- Total raised
- $52.6MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $52.6M2021-10-07
Funding rounds
- Round, 2021
- $52.6M2021-10-07, SEC form D sold, 11 investors
Products
- Other
- MZ-1866
Loading relationship preview